The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member
The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| CSL Behring | lectures | B |
| Grifols | jury of the "Annual ALTA (Alpha-1-Antitrypsin Laurell’s Training Awards) 2025" | B |
| Sanofi | lectures, advisory board | B |
| Amgen | lectures, congress participation | B |
| Chiesi | lectures, congress participation | B |
| Pfizer | lectures | B |
| Amgen | lectures | B |
| Chiesi | lectures | B |
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| Chiesi | travel grant | B |
| Amgen | travel grant | B |
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Irish Rugby Football Union | Ad hoc Consultancy work | B |
| Chinese Thoracic Society | Conference Lecture | B |
| American College of Cardiology | Content Development | A |
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| NovoNordisk | Unrestricted grant | C |
| Fitbit | Unrestricted grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| Astra Zeneca | Advisory Board/Invites speaker | Advisory Board/Invited speaker | B |
| GSK | Advisory Board/Invited speaker | Advisory Board/Invited speaker | A |
| Chiesi | Advisory Board/Invited speaker | Advisory Board/Invited speaker | A |
| Abdi İbrahim | Advisory Board/Invited speaker | Advisory Board/Invited speaker | A |
| Bilim | Advisory Board/Invited speaker | Advisory Board/Invited speaker | A |
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Astra Zeneca | Advisory Board/Invited speaker | A |
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| GINA Board of directors | GINA Support for travel | A |
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| TEVA pharmaceuticals | Honorarium for a non-promotional talk in a sponsored symposium at the ERS2022 | B |
| Sandoz pharmaceuticals | Honorarium for a non-promotional talk in a sponsored symposium at the PCRS 2022 | B |
None
None
None
| Company or organisation | Nature/Purpose of Support |
|---|---|
| International Primary Care Respiratory Group | Professional Society (multi-sponsorship from Industry) |
| Primary Care Respiratory Society | Professional Society (multi-sponsorship from Industry) |
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| various universities | Reviews, PhD defences | A |
| various teaching institutions | lectures outside my home university | A |
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| ERS | various conferences in my function as advocacy chair | C |
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| DFG | Research grant | D |
| BMBF | Research grant | D |
| German Environment Agency | Research grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.
He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
All ERS Assembly Heads are also members of the Executive Committee.